Pirandamine

This classification denotes a serotonin agonist with the molecular formula C17H23NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier WC6V8L1Z13, chemically known as 1,3,4,9-tetrahydro-n,n,1-trimethylindeno(1,2-c)-pyran-1,ethylamine hydrochloride but generally known as pirandamine, which bears US NIH Compound Identifier 216376. European Medicines Agency schedules Pirandamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09893MIG. The term PIRANDAMINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 29, No. 10 1975, List 15). PIRANDAMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule pirandamine under HS 29329985 and SITC 51569. As of Q4 2014, PIRANDAMINE remains the US FDA Preferred Term for this commodity. Pirandamine bears US NLM identifiers UMLS ID C0071125 and NCI Concept Code C84064. SMILES: O1C(C2=C(Cc3c2cccc3)CC1)(CCN(C)C)C.